Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia
1
x
$
30.00
Assessing Rates and Predictors of Tachyphylaxis
1
x
$
30.00
C. Philip O’Carroll, MD: Migraine And The Limbic System: Closing The Circle
1
x
$
30.00
Psychopharmacology: The ‘Combo Pills’-Did it find its way into Practice?
1
x
$
30.00
The Effectiveness of Long-Acting Injectable Risperidone in a Population of Psychiatric Out-Patients: 1-Year Naturalistic Study
1
x
$
30.00
Nota de los editores: Enfoque en la salud de la mujer latina
1
x
$
0.00
Bereavement During a Course of TMS for MDD: A Case Report
1
x
$
30.00
Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
1
x
$
30.00
View Cart
Checkout
Home
cytochrome-p-450
“Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)
$
30.00
Add to cart
Details
Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
$
30.00
Add to cart
Details
Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
$
30.00
Add to cart
Details
Page load link
Go to Top
